STRYKER CORP Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets
STRYKER CORP (SYK) reported Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets of 4.10% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets · last filed 2026-02-11
- STRYKER CORP defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets for fiscal 2025 was 4.10%, a 4.65% decline from fiscal 2024.
- STRYKER CORP defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets for fiscal 2024 was 4.30%, a 2.38% increase from fiscal 2023.
- STRYKER CORP defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets for fiscal 2023 was 4.20%, a 35.48% increase from fiscal 2022.
- STRYKER CORP defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets for fiscal 2022 was 3.10%, a 24.00% increase from fiscal 2021.
| Period end | Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets 12 month |
|---|---|
| 2025-12-31 | 4.10% 10-K · filed 2026-02-11 |
| 2024-12-31 | 4.30% 10-K · filed 2026-02-11 |
| 2023-12-31 | 4.20% 10-K · filed 2026-02-11 |
| 2022-12-31 | 3.10% 10-K · filed 2025-02-12 |
| 2021-12-31 | 2.50% 10-K · filed 2024-02-14 |
| 2020-12-31 | 2.90% 10-K · filed 2023-02-10 |
| 2019-12-31 | 3.50% 10-K · filed 2022-02-11 |
| 2018-12-31 | 3.30% 10-K · filed 2021-02-11 |
| 2017-12-31 | 3.30% 10-K · filed 2020-02-06 |
| 2016-12-31 | 3.60% 10-K · filed 2019-02-07 |
| 2015-12-31 | 4.00% 10-K · filed 2018-02-08 |
| 2014-12-31 | 3.70% 10-K · filed 2017-02-09 |
| 2013-12-31 | 3.70% 10-K · filed 2016-02-11 |
| 2012-12-31 | 4.20% 10-K · filed 2015-02-12 |
| 2011-12-31 | 4.60% 10-K · filed 2014-02-13 |
| 2010-12-31 | 5.20% 10-K · filed 2013-02-27 |
| 2009-12-31 | 5.80% 10-K · filed 2012-02-13 |
| 2008-12-31 | 5.50% 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |